Evidence map›Paper›PMID 23921808›Full record

ArticleNature methods2013

The CRAPome: a contaminant repository for affinity purification-mass spectrometry data.

Dattatreya Mellacheruvu, Zachary Wright, Amber L Couzens, Jean-Philippe Lambert, Nicole A St-Denis, Tuo Li, Yana V Miteva, Simon Hauri, Mihaela E Sardiu, Teck Yew Low and 28 more

Abstract read
In one paragraph

Article in Nature methods, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,049 papers.

0numbers the graph read from it
0cells of the map it votes in
1,049citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,049 citing papers in PubMed.

  1. Article
  2. Article
  3. Mutant p53Molecular oncology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

989 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Dattatreya MellacheruvuDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Zachary Wright
Amber L Couzens
Jean-Philippe Lambert
Nicole A St-Denis
Tuo Li
Yana V Miteva
Simon Hauri
Mihaela E Sardiu
Teck Yew Low
Vincentius A Halim
Richard D Bagshaw
Nina C Hubner
Abdallah Al-Hakim
Annie Bouchard
Denis Faubert
Damian Fermin
Wade H Dunham
Marilyn Goudreault
Zhen-Yuan Lin
Beatriz Gonzalez Badillo
Tony Pawson
Daniel Durocher
Benoit Coulombe
Ruedi Aebersold
Giulio Superti-Furga
Jacques Colinge
Albert J R Heck
Hyungwon Choi
Matthias Gstaiger
Shabaz Mohammed
Ileana M Cristea
Keiryn L Bennett
Mike P Washburn
Brian Raught
Rob M Ewing
Anne-Claude Gingras
Alexey I Nesvizhskii

Funding

COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
Proteomic Tools to Uncover the Role of Chromatin Remodeling in HIV-1 InfectionDP1DA026192 · NIDA · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 2008 to 2012
$3.9M
Molecular and Genetic Analysis of Castor in Cardiac DevelopmentR01HL112618 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, FRANK LEO · 2012 to 2016
$2.1M
Direct and Quantitative Proteomic Approaches in XenopusR21HD073044 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, FRANK LEO, CRISTEA, ILEANA M. · 2013 to 2014
$436k
Host Factors Required for Dengue and Yellow Fever Virus AmplificationR21AI102187 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CRISTEA, ILEANA M., THOMPSON, SUNNIE R · 2012 to 2013
$414k
TRANSCRIPTION FACTORS IN DEVELOPMENTR01CA016006 · NCI · ROCKEFELLER UNIVERSITY · PI DARNELL, JAMES E · 1985 to 1998
–
Austrian Science Fund FWF P 22282CIHR 82851-1CIHR MOP-82851CIHR MOP-84314NCI NIH HHS 1R21 CA16006001A1NHLBI NIH HHS HL112618-01NHLBI NIH HHS R01 HL112618NIAID NIH HHS R21 AI102187NICHD NIH HHS R21 HD073044NIDA NIH HHS DP1 DA026192NIDA NIH HHS DP1DA026192NIGMS NIH HHS 5R01GM94231NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

Affinity purification coupled with mass spectrometry (AP-MS) is a widely used approach for the identification of protein-protein interactions. However, for any given protein of interest, determining which of the identified polypeptides represent bona fide interactors versus those that are background contaminants (for example, proteins that interact with the solid-phase support, affinity reagent or epitope tag) is a challenging task. The standard approach is to identify nonspecific interactions using one or more negative-control purifications, but many small-scale AP-MS studies do not capture a complete, accurate background protein set when available controls are limited. Fortunately, negative controls are largely bait independent. Hence, aggregating negative controls from multiple AP-MS studies can increase coverage and improve the characterization of background associated with a given experimental protocol. Here we present the contaminant repository for affinity purification (the CRAPome) and describe its use for scoring protein-protein interactions. The repository (currently available for Homo sapiens and Saccharomyces cerevisiae) and computational tools are freely accessible at http://www.crapome.org/.

Indexed as

Chromatography, AffinityDatabases, FactualHumansMass SpectrometryProtein Interaction MappingProteinsProteomicsProteins

Identifiers

PMID23921808
PMCPMC3773500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.